FDA Drug Safety Communication: FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes
[FDA strengthens warning that non-aspirin nonsteroidal anti-inflammatory drugs (NSAIDs) can cause heart attacks or strokes (FDA Drug Safety Communication). Based on FDA ’s comprehensive review of new safety information, the agency is requiring updates to the drug labels of all prescription NSAIDs. Widely used to treat pain and fever from many different long- and short-term medical conditions such as arthritis, menstrual cramps, headaches, colds, and the flu, NSAI Ds are available by prescription and OTC. Examples of NSAIDs include ibuprofen, naproxen, diclofenac, and celecoxib. (Source: FDA Center for Drug Evaluation and...
Source: FDA Center for Drug Evaluation and Research - What's New - June 29, 2021 Category: Drugs & Pharmacology Authors: FDA Source Type: news
Pennsaid (diclofenac sodium)
Title: Pennsaid (diclofenac sodium)Category: MedicationsCreated: 5/19/2021 12:00:00 AMLast Editorial Review: 5/19/2021 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - May 19, 2021 Category: Rheumatology Source Type: news
Licart (diclofenac epolamine)
Title: Licart (diclofenac epolamine)Category: MedicationsCreated: 5/19/2021 12:00:00 AMLast Editorial Review: 5/19/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 19, 2021 Category: Drugs & Pharmacology Source Type: news
Flector Patch (diclofenac epolamine)
Title: Flector Patch (diclofenac epolamine)Category: MedicationsCreated: 5/13/2021 12:00:00 AMLast Editorial Review: 5/13/2021 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - May 13, 2021 Category: Drugs & Pharmacology Source Type: news
Diclofenac mitigates virulence of multidrug-resistant Staphylococcus aureus. Archives of microbiology 202(10): 2751-2760.
In conclusion, diclofenac can be used in combination with antibiotics as anti-virulence agent against MDR-MRSA which will enhance the ability of immune system to eradicate infection. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - January 15, 2021 Category: Consumer Health News Source Type: news
Extraction with an electric motor-driven handpiece may still cause subcutaneous emphysema - A case report
This article reported a case of SE around the paraorbital and submandibular regions through extractions of teeth 28 and 38. This 20-year-old man came to the emergency room at night with the major complaint of pain and discomfort during swallowing. Sudden swelling at his left face during extractions of teeth 28 and 38 three hours ago was mentioned. The original surgeon who performed the odontectomy was aware of the SE after removing the surgical drape and specific post-operation instructions were given as follows: immediate hospital care may be needed if the patient encountered difficulties in swallowing or any worsen compl...
Source: Dental Technology Blog - December 14, 2020 Category: Dentistry Source Type: news
NSAIDs not associated with more severe coronavirus disease, study finds
(PLOS) The use of non-steroidal anti-inflammatory drugs (NSAIDs), such as ibuprofen and diclofenac, is not associated with any adverse effects in people who have tested positive for COVID-19, according to a new study published September 8 in PLOS Medicine by Anton Potteg å rd of the University of Southern Denmark and colleagues from Aarhus University Hospital and the Danish Medicines Agency. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - September 8, 2020 Category: Infectious Diseases Source Type: news
Perrigo Announces FDA Approval for the Store Brand Equivalent of Voltaren(R) Arthritis Pain
DUBLIN, April 6, 2020 -- (Healthcare Sales & Marketing Network) -- Perrigo Company plc (NYSE: PRGO; TASE) today announced that it was the first to receive approval from the U.S. Food and Drug Administration for its abbreviated new drug application (ANDA) ... Biopharmaceuticals, Generics, FDA Perrigo, Voltaren, Voltaren Gel, diclofenac (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2020 Category: Pharmaceuticals Source Type: news
FDA approves GSK ’s Advil Dual Action with Acetaminophen for over-the-counter use in the United States
First combination of ibuprofen and acetaminophen for pain relief to be available OTC in 2020Issued: Warren, USGlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Advil Dual Action with Acetaminophen as an over-the-counter (OTC) product for pain relief. The exclusive formula is now the first FDA-approved OTC combination of ibuprofen and acetaminophen in the United States and will be available over-the-counter nationwide in 2020.Franck Riot, Head of R&D, GSK Consumer Healthcare said: “For decades, many consumers have been using ibuprofen and acetaminophen to get...
Source: Dental Technology Blog - March 6, 2020 Category: Dentistry Source Type: news
Low-dose Diclofenac to Control Fever After Ischemic Stroke Low-dose Diclofenac to Control Fever After Ischemic Stroke
Central fever following ischemic stroke is fairly common and associated with worse outcomes. Might the NSAID diclofenac sodium be an effective antipyretic in this situation?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 25, 2020 Category: Consumer Health News Tags: Family Medicine/Primary Care Journal Article Source Type: news
FDA approves GSK's Voltaren Arthritis Pain for over-the-counter use in the United States
GlaxoSmithKline (LSE/NYSE: GSK) announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis pain reliever) as an over-the-counter (OTC) product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, ankle or knee in adults (18 years and older). (Source: World Pharma News)
Source: World Pharma News - February 20, 2020 Category: Pharmaceuticals Tags: Featured GlaxoSmithKline Business and Industry Source Type: news
FDA Approves Voltaren Arthritis Pain, Pataday for OTC Use
Title: FDA Approves Voltaren Arthritis Pain, Pataday for OTC UseCategory: Health NewsCreated: 2/19/2020 12:00:00 AMLast Editorial Review: 2/20/2020 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - February 20, 2020 Category: Rheumatology Source Type: news
FDA Approves Voltaren Arthritis Pain, Pataday for OTC Use
WEDNESDAY, Feb. 19, 2020 -- The U.S. Food and Drug Administration approved three drugs for nonprescription, over-the-counter use -- Voltaren Arthritis Pain (diclofenac sodium topical gel, 1 percent), Pataday Twice Daily Relief (olopatadine HCl... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 19, 2020 Category: General Medicine Source Type: news
Diclostream (Diclofenac Sodium 1.5% Solution and Menthol 10% Topical Liquid) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 19, 2020 Category: Drugs & Pharmacology Source Type: news
FDA Approves GSK ’s Voltaren Arthritis Pain for Over-the-Counter Use in the United States
Warren, New Jersey, USA -- February 17, 2020 -- GlaxoSmithKline (LSE/NYSE: GSK) today announced that the U.S. Food and Drug Administration (FDA) has approved Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID)- arthritis... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - February 17, 2020 Category: Drugs & Pharmacology Source Type: news
